PubMed=9637538; DOI=10.4049/jimmunol.160.12.6188
Gueguen M., Patard J.-J., Gaugler B., Brasseur F., Renauld J.-C., Van Cangh P.J., Boon T., van den Eynde B.J.
An antigen recognized by autologous CTLs on a human bladder carcinoma.
J. Immunol. 160:6188-6194(1998)

PubMed=11051255
Gala J.-L., Loric S., Guiot Y., Denmeade S.R., Gady A., Brasseur F., Heusterspreute M., Eschwege P., De Nayer P., Van Cangh P.J., Tombal B.
Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?
Clin. Cancer Res. 6:4049-4054(2000)

PubMed=11751535; DOI=10.1093/clinchem/48.1.25
Zammatteo N., Lockman L., Brasseur F., De Plaen E., Lurquin C., Lobert P.-E., Hamels S., Boon T., Remacle J.
DNA microarray to monitor the expression of MAGE-A genes.
Clin. Chem. 48:25-34(2002)

PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)